Literature DB >> 12118051

Impact numbers in health policy decisions.

J Attia1, J Page, R F Heller, A J Dobson.   

Abstract

OBJECTIVE: To outline the major methodological issues appropriate to the use of the population impact number (PIN) and the disease impact number (DIN) in health policy decision making.
DESIGN: Review of literature and calculation of PIN and DIN statistics in different settings.
SETTING: Previously proposed extensions to the number needed to treat (NNT): the DIN and the PIN, which give a population perspective to this measure. MAIN
RESULTS: The PIN and DIN allow us to compare the population impact of different interventions either within the same disease or in different diseases or conditions. The primary studies used for relative risk estimates should have outcomes, time periods and comparison groups that are congruent and relevant to the local setting. These need to be combined with local data on disease rates and population size. Depending on the particular problem, the target may be disease incidence or prevalence and the effects of interest may be either the incremental impact or the total impact of each intervention. For practical application, it will be important to use sensitivity analyses to determine plausible intervals for the impact numbers.
CONCLUSIONS: Attention to various methodological issues will permit the DIN and PIN to be used to assist health policy makers assign a population perspective to measures of risk.

Mesh:

Year:  2002        PMID: 12118051      PMCID: PMC1732219          DOI: 10.1136/jech.56.8.600

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  18 in total

1.  Estimating the number needed to treat (NNT) index when the data are subject to error.

Authors:  S D Walter; L Irwig
Journal:  Stat Med       Date:  2001-03-30       Impact factor: 2.373

2.  Disease impact number and population impact number: population perspectives to measures of risk and benefit.

Authors:  R F Heller; A J Dobson
Journal:  BMJ       Date:  2000-10-14

3.  An/atomy

Authors: 
Journal:  BMJ       Date:  2000-10-14

4.  A population perspective to evidence based medicine: "evidence for population health".

Authors:  R F Heller; J Page
Journal:  J Epidemiol Community Health       Date:  2002-01       Impact factor: 3.710

5.  Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials.

Authors:  R E Hendrick; R A Smith; J H Rutledge; C R Smart
Journal:  J Natl Cancer Inst Monogr       Date:  1997

6.  An assessment of clinically useful measures of the consequences of treatment.

Authors:  A Laupacis; D L Sackett; R S Roberts
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

7.  The number needed to treat: a clinically useful measure of treatment effect.

Authors:  R J Cook; D L Sackett
Journal:  BMJ       Date:  1995-02-18

Review 8.  Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to be treated for one additional patient to be harmed".

Authors:  L M Bjerre; J LeLorier
Journal:  BMJ       Date:  2000-02-19

9.  Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction.

Authors:  E F Philbin; R N Santella; T A Rocco
Journal:  J Am Geriatr Soc       Date:  1999-03       Impact factor: 5.562

10.  Death and readmission in the year after hospital admission with cardiovascular disease: the Hunter Area Heart and Stroke Register.

Authors:  R F Heller; J D Fisher; C A D'Este; L L Lim; A J Dobson; R Porter
Journal:  Med J Aust       Date:  2000-03-20       Impact factor: 7.738

View more
  6 in total

1.  Alternative metrics for assessing clinical benefit with immunotherapy in oncology.

Authors:  E Chan; C Quinn; I Hirji; J Hillengass; K Anderson; A Oukessou; C Davis
Journal:  Oncoimmunology       Date:  2018-05-07       Impact factor: 8.110

2.  Using and Interpreting Adjusted NNT Measures in Biomedical Research.

Authors:  Ralf Bender
Journal:  Open Dent J       Date:  2010-07-16

3.  Number needed to treat (NNT) in clinical literature: an appraisal.

Authors:  Diogo Mendes; Carlos Alves; Francisco Batel-Marques
Journal:  BMC Med       Date:  2017-06-01       Impact factor: 8.775

4.  Helping to prioritise interventions for depression and schizophrenia: use of Population Impact Measures.

Authors:  Richard F Heller; Islay Gemmell; Lesley Patterson
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-03-22

5.  Assessing the impact of heart failure specialist services on patient populations.

Authors:  Georgios Lyratzopoulos; Gary A Cook; Patrick McElduff; Daniel Havely; Richard Edwards; Richard F Heller
Journal:  BMC Health Serv Res       Date:  2004-05-24       Impact factor: 2.655

6.  What are the benefits of cognitive enhancers for Alzheimer's Disease: use of Population Impact Measures.

Authors:  Udaya P Gammanpila; Alistair Burns; Richard F Heller; Nitin Purandare
Journal:  BMC Geriatr       Date:  2007-11-06       Impact factor: 3.921

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.